10 20 30 40 50 60 70 80 1WMA - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER OXIDOREDUCTASE 06-JUL-04 1WMA
TITLE CRYSTAL STRUCTURE OF HUMAN CBR1 IN COMPLEX WITH HYDROXY-PP
COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBONYL REDUCTASE [NADPH] 1; COMPND 3 CHAIN: A; COMPND 4 EC: 1.1.1.184; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-11A
KEYWDS OXIDOREDUCTASE
EXPDTA X-RAY DIFFRACTION
AUTHOR D.RAUH,R.BATEMAN,K.M.SHOKAT
REVDAT 3 24-FEB-09 1WMA 1 VERSN REVDAT 2 21-JUN-05 1WMA 1 JRNL REVDAT 1 26-APR-05 1WMA 0
JRNL AUTH M.TANAKA,R.BATEMAN,D.RAUH,E.VAISBERG, JRNL AUTH 2 S.RAMACHANDANI,C.ZHANG,K.C.HANSEN,A.L.BURLINGAME, JRNL AUTH 3 J.K.TRAUTMAN,K.M.SHOKAT,C.L.ADAMS JRNL TITL AN UNBIASED CELL MORPHOLOGY-BASED SCREEN FOR NEW, JRNL TITL 2 BIOLOGICALLY ACTIVE SMALL MOLECULES JRNL REF PLOS BIOL. V. 3 128 2005 JRNL REFN ISSN 1544-9173 JRNL PMID 15799708 JRNL DOI 10.1371/JOURNAL.PBIO.0030128
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.24 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.109 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : 0.167 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 4439 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 78110 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.104 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.160 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 4020 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 71819 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2312 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 173 REMARK 3 SOLVENT ATOMS : 365 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2626.50 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1878.61 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 31 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 25751 REMARK 3 NUMBER OF RESTRAINTS : 33293 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 ANGLE DISTANCES (A) : 0.029 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.024 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.070 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.077 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.027 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.046 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.092 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1WMA COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-JUL-04. REMARK 100 THE RCSB ID CODE IS RCSB023736.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.11587 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 155494 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.240 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.12100 REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION, HANGING DROP, PH REMARK 280 6.0
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.22500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.96500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.67500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.96500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.22500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.67500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1
REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLN A 67 CD OE1 NE2 REMARK 480 GLU A 152 CD OE2 REMARK 480 GLN A 155 CD OE1 NE2 REMARK 480 LYS A 216 CG CD CE NZ REMARK 480 LYS A 219 CD CE NZ REMARK 480 ASP A 259 CB CG OD1 OD2 REMARK 480 GLU A 261 CB CG CD OE1 OE2 REMARK 480 ARG A 272 CD
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 41 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG A 57 NE - CZ - NH2 ANGL. DEV. = 7.2 DEGREES REMARK 500 ARG A 73 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG A 77 CD - NE - CZ ANGL. DEV. = 9.1 DEGREES REMARK 500 ARG A 118 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 118 NE - CZ - NH2 ANGL. DEV. = -6.8 DEGREES REMARK 500 ARG A 205 NE - CZ - NH1 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG A 209 NE - CZ - NH2 ANGL. DEV. = -5.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 114 -60.34 -98.21 REMARK 500 SER A 138 -131.55 -98.00 REMARK 500 REMARK 500 REMARK: NULL
REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 P33 A 311
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 300 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 301 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 302 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 303 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 304 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 305 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 306 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AB3 A 307 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AB3 A 308 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 309 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PE5 A 310 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P33 A 311
DBREF 1WMA A 1 276 UNP P16152 DHCA_HUMAN 1 276
SEQRES 1 A 276 SER SER GLY ILE HIS VAL ALA LEU VAL THR GLY GLY ASN SEQRES 2 A 276 LYS GLY ILE GLY LEU ALA ILE VAL ARG ASP LEU CYS ARG SEQRES 3 A 276 LEU PHE SER GLY ASP VAL VAL LEU THR ALA ARG ASP VAL SEQRES 4 A 276 THR ARG GLY GLN ALA ALA VAL GLN GLN LEU GLN ALA GLU SEQRES 5 A 276 GLY LEU SER PRO ARG PHE HIS GLN LEU ASP ILE ASP ASP SEQRES 6 A 276 LEU GLN SER ILE ARG ALA LEU ARG ASP PHE LEU ARG LYS SEQRES 7 A 276 GLU TYR GLY GLY LEU ASP VAL LEU VAL ASN ASN ALA GLY SEQRES 8 A 276 ILE ALA PHE LYS VAL ALA ASP PRO THR PRO PHE HIS ILE SEQRES 9 A 276 GLN ALA GLU VAL THR MET LYS THR ASN PHE PHE GLY THR SEQRES 10 A 276 ARG ASP VAL CYS THR GLU LEU LEU PRO LEU ILE LYS PRO SEQRES 11 A 276 GLN GLY ARG VAL VAL ASN VAL SER SER ILE MET SER VAL SEQRES 12 A 276 ARG ALA LEU LYS SER CYS SER PRO GLU LEU GLN GLN LYS SEQRES 13 A 276 PHE ARG SER GLU THR ILE THR GLU GLU GLU LEU VAL GLY SEQRES 14 A 276 LEU MET ASN LYS PHE VAL GLU ASP THR LYS LYS GLY VAL SEQRES 15 A 276 HIS GLN LYS GLU GLY TRP PRO SER SER ALA TYR GLY VAL SEQRES 16 A 276 THR LYS ILE GLY VAL THR VAL LEU SER ARG ILE HIS ALA SEQRES 17 A 276 ARG LYS LEU SER GLU GLN ARG LYS GLY ASP LYS ILE LEU SEQRES 18 A 276 LEU ASN ALA CYS CYS PRO GLY TRP VAL ARG THR ASP MET SEQRES 19 A 276 ALA GLY PRO LYS ALA THR LYS SER PRO GLU GLU GLY ALA SEQRES 20 A 276 GLU THR PRO VAL TYR LEU ALA LEU LEU PRO PRO ASP ALA SEQRES 21 A 276 GLU GLY PRO HIS GLY GLN PHE VAL SER GLU LYS ARG VAL SEQRES 22 A 276 GLU GLN TRP
HET SO4 A 300 5 HET SO4 A 301 5 HET SO4 A 302 5 HET SO4 A 303 5 HET SO4 A 304 5 HET SO4 A 305 5 HET SO4 A 306 5 HET AB3 A 307 21 HET AB3 A 308 21 HET NDP A 309 48 HET PE5 A 310 27 HET P33 A 311 21
HETNAM SO4 SULFATE ION HETNAM AB3 3-(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3- HETNAM 2 AB3 YL)PHENOL HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM PE5 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL HETNAM P33 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL
HETSYN PE5 2-(2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}- HETSYN 2 PE5 ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL, POLYETHYLENE HETSYN 3 PE5 GLYCOL PEG400 HETSYN P33 HEPTAETHYLENE GLYCOL, PEG330
FORMUL 2 SO4 7(O4 S 2-) FORMUL 9 AB3 2(C15 H17 N5 O) FORMUL 11 NDP C21 H30 N7 O17 P3 FORMUL 12 PE5 C18 H38 O9 FORMUL 13 P33 C14 H30 O8 FORMUL 14 HOH *365(H2 O)
HELIX 1 1 LYS A 14 PHE A 28 1 15 HELIX 2 2 ASP A 38 GLU A 52 1 15 HELIX 3 3 ASP A 65 GLY A 81 1 17 HELIX 4 4 PRO A 101 PHE A 114 1 14 HELIX 5 5 PHE A 114 LEU A 125 1 12 HELIX 6 6 SER A 139 SER A 148 1 10 HELIX 7 7 SER A 150 SER A 159 1 10 HELIX 8 8 THR A 163 LYS A 180 1 18 HELIX 9 9 SER A 191 ARG A 215 1 25 HELIX 10 10 SER A 242 ALA A 247 1 6 HELIX 11 11 ALA A 247 LEU A 255 1 9
SHEET 1 A 8 ARG A 57 GLN A 60 0 SHEET 2 A 8 ASP A 31 ALA A 36 1 N VAL A 32 O ARG A 57 SHEET 3 A 8 VAL A 6 VAL A 9 1 N ALA A 7 O VAL A 33 SHEET 4 A 8 LEU A 83 ASN A 88 1 O VAL A 87 N LEU A 8 SHEET 5 A 8 ILE A 128 VAL A 137 1 O VAL A 137 N ASN A 88 SHEET 6 A 8 LEU A 221 CYS A 226 1 O ASN A 223 N ASN A 136 SHEET 7 A 8 PHE A 267 SER A 269 1 O VAL A 268 N ALA A 224 SHEET 8 A 8 ARG A 272 GLU A 274 -1 O GLU A 274 N PHE A 267
CISPEP 1 GLY A 262 PRO A 263 0 3.22
SITE 1 AC1 4 ARG A 57 PHE A 58 HOH A 542 HOH A 639 SITE 1 AC2 10 PHE A 102 SER A 190 SER A 191 ALA A 192 SITE 2 AC2 10 TYR A 193 SO4 A 305 HOH A 424 HOH A 458 SITE 3 AC2 10 HOH A 553 HOH A 559 SITE 1 AC3 7 LYS A 216 GLY A 217 ASP A 218 LYS A 219 SITE 2 AC3 7 HOH A 506 HOH A 511 HOH A 761 SITE 1 AC4 9 ASP A 64 LYS A 111 THR A 163 ARG A 209 SITE 2 AC4 9 LYS A 210 GLU A 213 HOH A 446 HOH A 460 SITE 3 AC4 9 HOH A 677 SITE 1 AC5 6 ARG A 41 ARG A 118 HOH A 571 HOH A 656 SITE 2 AC5 6 HOH A 675 HOH A 684 SITE 1 AC6 8 VAL A 96 ALA A 97 ARG A 272 SO4 A 301 SITE 2 AC6 8 HOH A 502 HOH A 553 HOH A 559 HOH A 576 SITE 1 AC7 6 SER A 2 GLY A 3 GLN A 47 GLN A 50 SITE 2 AC7 6 LYS A 129 HOH A 742 SITE 1 AC8 9 SER A 139 MET A 141 TYR A 193 GLY A 228 SITE 2 AC8 9 TRP A 229 AB3 A 308 NDP A 309 PE5 A 310 SITE 3 AC8 9 HOH A 479 SITE 1 AC9 10 ARG A 22 ARG A 26 ILE A 140 ARG A 144 SITE 2 AC9 10 GLU A 244 AB3 A 307 PE5 A 310 HOH A 484 SITE 3 AC9 10 HOH A 607 HOH A 642 SITE 1 BC1 39 GLY A 11 ASN A 13 LYS A 14 GLY A 15 SITE 2 BC1 39 ILE A 16 ARG A 37 LEU A 61 ASP A 62 SITE 3 BC1 39 ILE A 63 ASP A 64 ASN A 89 ALA A 90 SITE 4 BC1 39 GLY A 91 ILE A 92 VAL A 137 SER A 138 SITE 5 BC1 39 TYR A 193 LYS A 197 PRO A 227 GLY A 228 SITE 6 BC1 39 TRP A 229 VAL A 230 THR A 232 ASP A 233 SITE 7 BC1 39 MET A 234 ALA A 235 AB3 A 307 HOH A 402 SITE 8 BC1 39 HOH A 406 HOH A 407 HOH A 430 HOH A 449 SITE 9 BC1 39 HOH A 481 HOH A 523 HOH A 549 HOH A 661 SITE 10 BC1 39 HOH A 664 HOH A 666 HOH A 721 SITE 1 BC2 13 ASP A 23 ALA A 93 MET A 141 ARG A 144 SITE 2 BC2 13 MET A 234 GLU A 248 TYR A 252 AB3 A 307 SITE 3 BC2 13 AB3 A 308 HOH A 416 HOH A 423 HOH A 466 SITE 4 BC2 13 HOH A 495 SITE 1 BC3 10 ALA A 93 THR A 122 LEU A 125 HIS A 207 SITE 2 BC3 10 LYS A 210 LEU A 211 GLN A 214 HOH A 623 SITE 3 BC3 10 HOH A 697 HOH A 730
CRYST1 54.450 55.350 95.930 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018365 0.000000 0.000000 0.00000
SCALE2 0.000000 0.018067 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010424 0.00000